It is really sad how the major networds refuse to engage in real journalism anymore. In contrast, here is a great article on PBS discussing how the healthcare industry is spending millions of dollars on lobbying and campaign contributions to block healthcare reform. Yet, many folks on DU attack President Obama and blame him for the fact that the message is being garbled, as though fighting billion dollar special interests would be easy. There is a reason why healthcare reform has not happened for decades, and why President Obama is encountering such steep opposition from so called "centrists" in his own party. Here is a story that you just will not see on the major networks.
http://www.pbs.org/moyers/journal/07312009/profile2.html###
In his conversation with Bill Moyers, former CIGNA executive Wendell Potter spoke of the hold profits have on health care policy. "It does offend me that the vested special interests, who are so profitable and so powerful, are able to influence public policy in the way that they have, and the way that they've done over the years. And the insurance industry has been one of the most successful, in beating back any kinds of legislation that would hinder or affect the profitability of the companies."
On July 6, 2009 the WASHINGTON POST reported on two aspects of this easy flow between government and industry, money and politics. "Familiar Players in Health Bill Lobbying Firms Are Enlisting Ex-Lawmakers, Aides," documents the revolving door: "The nation's largest insurers, hospitals and medical groups have hired more than 350 former government staff members and retired members of Congress in hopes of influencing their old bosses and colleagues, according to an analysis of lobbying disclosures and other records."
In addition, the POST story calculated the amount that the health industry is spending to lobby against elements of proposed health care reform to the tune of $1.4 million a day. Indeed, "Pharmaceutical Research and Manufacturers of America (PhRMA) doubled its spending to nearly $7 million in the first quarter of 2009, followed by Pfizer, with more than $6 million."
###